Moma Therapeutics
Clinical trials sponsored by Moma Therapeutics, explained in plain language.
-
New oral drug targets genetic weakness in advanced cancers
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called MOMA-313, given alone or combined with an existing cancer drug (olaparib), in people with advanced solid tumors that have a specific genetic flaw. The main goals are to find safe doses and see how the body processes the dru…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for tough cancers: first human trial of experimental pill begins
Disease control Recruiting nowThis is the first human study testing a new oral drug called MOMA-341 for people with advanced solid tumors that have specific genetic features (MSI-H or dMMR). The main goal is to find safe doses and see how the body handles the drug when taken alone or combined with other cance…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC